Exogenous sample contamination. Sources and interference

Clinical Biochemistry

Volumn 49, Issue 18, 2016, Pages 1340-1345

  Cornes, Michael P ^a  

^a ROYAL WOLVERHAMPTON HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

Exogenous; Interference; Pre analytical

Indexed keywords

ANTIBODY; CITRATE SODIUM; CONTRAST MEDIUM; DISINFECTANT AGENT; DOMESTIC CHEMICAL; DRUG; EDETIC ACID; FLUORIDE; GELLING AGENT; HEPARIN; HERBACEOUS AGENT; INFUSION FLUID; REAGENT;

ARTICLE; BLOOD COLLECTION TUBE; BUDGET; CLINICAL LABORATORY; CONTAMINATION; EXOGENOUS INTERFERENCE; HOSPITAL; HUMAN; IMMUNOASSAY; PATIENT CARE; PATIENT SAFETY; PRIORITY JOURNAL; QUALITY CONTROL; SAMPLE; ARTIFACT; LABORATORY;

ARTIFACTS; HUMANS; LABORATORIES;

EID: 84994414366     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2016.09.014     Document Type: Article

References (80)

1. [1] Hallworth, M.J., The ‘70% claim’: what is the evidence base?. Ann. Clin. Biochem. 48:Pt 6 (Nov 2011), 487–488, 10.1258/acb.2011.011177.
2. [2] Forsman, R.W., Why is the laboratory an afterthought for managed care organizations?. Clin. Chem. 42 (1996), 813–816.
3. [3] Stankovic, A.K., Smith, S., Elevated serum potassium values: the role of preanalytic variables. Am. J. Clin. Pathol. 121 (2004), S105–S112 (Suppl).
4. [4] Green, S.F., The cost of poor blood specimen quality and errors in preanalytical processes. Clin. Biochem. 46 (2013), 1175–1179.
5. [5] Sturgeon, C.M., Viljoen, A., Analytical error and interference in immunoassay: minimizing risk. Ann. Clin. Biochem. 48:Pt 5 (Sep 2011), 418–432.
6. [6] Gandhi, M.J., Narra, V.R., Brown, J.J., Guo, A., Grosu, D.S., Parvin, C.A., Scott, M.G., Clinical and economic impact of falsely decreased calcium values caused by gadoversetamide interference. AJR Am. J. Roentgenol. 190 (2008), W213–W217.
7. [7] Cornes, M.P., Ford, C., Gama, R., Undetected spurious hypernatraemia wastes health-care resources. Ann. Clin. Biochem. 48:Pt 1 (Jan 2011), 87–88.
8. [8] Bjerner, J., Nustad, K., Norum, L.F., et al. Immunometric assay interference: incidence and prevention. Clin. Chem. 48 (2002), 613–621.
9. [9] Ismail, A.A., Walker, P.L., Barth, J.H., et al. Wrong biochemistry results: two case reports and observational study in 5310 patients on potentially misleading thyroid-stimulating hormone and gonadotropin immunoassay results. Clin. Chem. 48 (2002), 2023–2029.
10. [10] Kroll, M.H., Elin, R.J., Interference with clinical laboratory analyses. Clin. Chem. 40:11 Pt 1 (Nov 1994), 1996–2005 (Review. Erratum in: Clin Chem 1995 May;41(5):770).
11. [11] Powers, D.M., Boyd, J.C., Glick, M.R., Kotachi, M.L., Letellier, G., Miller, W.G., et al. Interferance testing in clinical chemistry; proposed guidelines. NCCLS Document EP7-P, 1986, National Committee for Clinical Laboratory Standards, Villanova, PA.
12. [12] Clinical Laboratory Standards Institute (CLSI) interference testing in clinical chemistry, Approved guidelines. 2005, CLSI publication EP7-A2.
13. [13] Tate, J., Ward, G., Interferences in immuno assay. Clin. Biochem. Rev. 25 (2004), 105–120.
14. [14] Dimeski, G., Interference testing. Clin. Biochem. Rev. 29:Suppl. 1 (Aug 2008), S43–S48.
15. [15] Sulaiman, R.A., Twomey, P.J., Gama, R., Mitigation and detection of spurious potassium and sodium results. Clin. Chim. Acta 412:1–2 (Jan 14 2011), 1–6, 10.1016/j.cca.2010.08.028 (Epub 2010 Aug 25).
16. [16] Guder, W.G., Narayanan, S., Wisser, H., Zawta, B., Samples: From the Patient to the Laboratory. 3th ed., 2003, Wiley-VCH GmbH & Co:KgaA, Weinheim.
17. [17] Tryding, N., Drug Effects in Clinical Chemistry. 1977, Apoteksbolaget, Stockholm.
18. [18] Young, D.S., Pestaner, lC., Gibberman, V., Effects of drugs on clinical laboratory tests. Clin. Chem. 21 (1975), 1D–423D.
19. [19] http://clinfx.wiley.com/aaccweb/aacc/ Accessed 14/09/16.
20. [20] Young, D.S., 5th ed. Effects of Drugs on Clinical Laboratory Tests, vol. 1 + 2, 2000, AACC press, Washington.
21. [21] Caraci, F., Crupi, R., Drago, F., Spina, E., Metabolic drug interactions between antidepressants and anticancer drugs: focus on selective serotonin reuptake inhibitors and hypericum extract. Curr. Drug Metab. 12 (2011), 570–577.
22. [22] Unger, M., Pharmacokinetic drug interactions involving Ginkgo biloba. Drug Metab. Rev. 45 (2013), 353–385.
23. [23] Begcevic, I., Simundic, A.M., Nikolac, N., Dobrijevic, S., Rajkovic, M.G., Tesija-Kuna, A., Can cranberry extract and vitamin C + Zn supplements affect the in vivo activity of paraoxonase 1, antioxidant potential, and lipid status?. Clin. Lab. 59 (2013), 1053–1060.
24. [24] James, D., Devaraj, S., Bellur, P., Lakkanna, S., Vicini, J., Boddupalli, S., Novel concepts of broccoli sulforaphanes and disease: induction of phase II antioxidant and detoxification enzymes by enhanced-glucoraphanin broccoli. Nutr. Rev. 70 (2012), 654–665.
25. [25] Bressler, R., Grapefruit juice and drug interactions. Exploring mechanisms of this interaction and potential toxicity for certain drugs. Geriatrics 61 (2006), 12–18.
26. [26] Miller, A.G., Brown, H., Degg, T., Allen, K., Keevil, B.G., Measurement of plasma 5-hydroxyindole acetic acid by liquid chromatography tandem mass spectrometry–comparison with HPLC methodology. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 878:7–8 (Mar 1 2010), 695–699.
27. [27] Meites, S., Skin-puncture and blood-collecting technique for infants: update and problems. Clin. Chem. 34:9 (Sep 1988), 1890–1894 (Review).
28. [28] Bach, P.R., When a sodium is not a sodium. Pediatr. Lab. Med., 9, 1991, 5.
29. [29] Cornes, M.P., Ford, C., Gama, R., Spurious hyperkalaemia due to EDTA contamination: common and not always easy to identify. Ann. Clin. Biochem. 45:Pt 6 (Nov 2008), 601–603.
30. [30] Cornes, M., van Dongen-Lases, E., Grankvist, K., Ibarz, M., Kristensen, G., Lippi, G., Nybo, M., Simundic, A.M., Order of blood draw: opinion paper by the European Federation for Clinical Chemistry and Laboratory Medicine (EFLM) working group for the preanalytical phase (WG-PRE). Working group for preanalytical phase (WG-PRE), European Federation of Clinical Chemistry and Laboratory Medicine (EFLM). Clin. Chem. Lab. Med., Jul 21 2016.
31. [31] Hadley, G.G., Weiss, S.P., Further notes on the use of salts of ethylenediamine tetraacetic acid (EDTA) as anticoagulants. Am. J. Clin. Pathol. 25 (1955), 1090–1093.
32. [32] Imafuku, Y., Meguro, S., Kanno, K., et al. The effects of EDTA contaminated sera on laboratory data. Clin. Chim. Acta 325 (2002), 105–111.
33. [33] Koopman, B.J., Hindricks, F.R., Lokerse, Y.G., Wolthers, B.G., Orverdijk, J.F., Injurious effect of EDTA contamination on colorimetry of serum iron. Clin. Chem. 31 (1985), 2030–2032.
34. [34] Kolthoff, I.M., Sandell, E.B., Meehan, E.J., Bruckenstein, S., Quantitative Chemical Analysis. 4th edn., 1969, 1150.
35. [35] Davidson, D.F., Effects of contamination of blood specimens with liquid potassium-EDTA anticoagulant. Ann. Clin. Biochem. 39 (2002), 273–280.
36. [36] Fitzpatrick, M.F., Newell, J., Grimes, H., Egan, E.L., Spurious increase in plasma potassium concentration and reduction in plasma calcium due to in vitro contamination with liquid potassium edetic acid at phlebotomy. J. Clin. Pathol., 40, 1987, 588.
37. [37] Sharratt, C.L., Gilbert, C.J., Cornes, M.C., Ford, C., Gama, R., EDTA sample contamination is common and often undetected, putting patients at unnecessary risk of harm. Int. J. Clin. Pract. 63:8 (Aug 2009), 1259–1262.
38. [38] Naguib, M.T., Evans, N., Combined false hyperkalaemia and hypocalcaemia due to specimen contamination during routine phlebotomy. South. Med. J. 95 (2002), 1180–1186.
39. [39] Srivastava, R., Murphy, M.J., Card, J., Severn, A., Fraser, C.G., The case of the floating gel. J. Clin. Pathol. 57 (2004), 1333–1334.
40. [40] Lamb, E.J., Abbas, N.A., Spurious hypernatraemia and Citra-Lock. Ann. Clin. Biochem., 44, 2007, 579.
41. [41] Jeffrey, J., Ayling, R.M., A simple method for excluding Citra-Lock™ contamination. Ann. Clin. Biochem., 45, 2008, 448.
42. [42] Meng, Q.H., Krahn, J., Lithium heparinised blood-collection tubes give falsely low albumin results with an automated bromcresol green method in haemodialysis patients. Clin. Chem. Lab. Med. 46 (2008), 396–400.
43. [43] Jones, A.M., Honour, J.W., Unusual results from immunoassays and the role of the clinical endocrinologist. Clin. Endocrinol. 64:3 (Mar 2006), 234–244.
44. [44] Lima-Oliveira, G., Lippi, G., Salvagno, G.L., Montagnana, M., Picheth, G., Guidi, G.C., Preanalytical management: serum vacuum tubes validation for routine clinical chemistry. Biochem. Med. (Zagreb) 22 (2012), 180–186.
45. [45] Bowen, R.A.R., Chan, Y., Ruddel, M.E., Hortin, G.L., Csako, G., Demosky, S.J., et al. Immunoassay interference by a commonly used blood collection tube additive, the organosilicone surfactant silwet L-720. Clin. Chem. 51 (2005), 1874–1882.
46. [46] Narayanan, S., The preanalytic phase: an important component of laboratory medicine. Am. J. Clin. Pathol. 113 (2000), 429–452.
47. [47] Bush, V., Cohen, R., The evolution of blood collection tubes. Lab. Med. 34 (2003), 304–310.
48. [48] Faught, R.C., Marshall, J., Bornhorst, J., Solution densities and estimated total protein contents associated with inappropriate flotation of separator gel in different blood collection tubes. Arch. Pathol. Lab. Med. 135 (2011), 1081–1084.
49. [49] Gerin, F., Ramazan, D.C., Baykan, O., Sirikci, O., Haklar, G., Abnormal gel flotation in a patient with apperant pneumonia diagnosis: a case report. Biochem. Med. (Zagreb) 24:1 (2014 Feb), 180–182.
50. [50] Koch, T.R., Platoff, G., Suitability of collection tubes with separator gels for therapeutic drug monitoring. Ther. Drug Monit. 12 (1990), 277–280.
51. [51] Bergqvist, Y., Eckerbom, S., Funding, L., Effect of use of gel-barrier sampling tubes on determination of some antiepileptic drugs in serum. Clin. Chem. 30 (1984), 465–466.
52. [52] Chance, J., Berube, J., Vandersmissen, M., Blanckaert, N., Evaluation of the BD Vacutainer PST II blood collection tube for special chemistry analytes. Clin. Chem. Lab. Med. 47 (2009), 358–361.
53. [53] Shi, R.Z., van Rossum, H.H., Bowen, R.A., Serum testosterone quantitation by liquid chromatography–tandem mass spectrometry: interference from blood collection tubes. Clin. Biochem. 45 (2012), 1706–1709.
54. [54] Gounden, V., Soldin, S.J., Clinical use of reference intervals derived from some CALIPER studies questioned. Clin. Chem. 60 (2014), 416–417.
55. [55] Bowen, R.A., Remaley, A.T., Interferences from blood collection tube components on clinical chemistry assays. Biochem. Med. (Zagreb) 24:1 (Feb 15 2014), 31–44, 10.11613/BM.2014.006.
56. [56] Ng, W.Y., Yeo, C.P., Thrombin-accelerated quick clotting serum tubes: an evaluation with 22 common biochemical analytes. Adv. Hematol., 2013, 2013, 769479.
57. [57] Bowen, R.A., Hortin, G.L., Csako, G., Otanez, O.H., Remaley, A.T., Impact of blood collection devices on clinical chemistry assays. Clin. Biochem. 43 (2010), 4–25.
58. [58] Bush, V., Leonard, L., Szamosi, D.I., Advancements in blood collection devices. Lab. Med. 29 (2008), 616–622.
59. [59] Bowen, R.A., Chan, Y., Cohen, J., Rehak, N.N., Hortin, G.L., Csako, G., Remaley AT effect of blood collection tubes on total triiodothyronine and other laboratory assays. Clin. Chem. 51:2 (Feb 2005), 424–433.
60. [60] Shah, V.P., Knapp, G., Skelly, J.P., Cabana, B.E., Interference with measurements of certain drugs in plasma by a plasticizer in vacutainer tubes. Clin. Chem. 28 (1982), 2327–2328.
61. [61] van den Besselaar, A.M., van Dam, W., Sturk, A., Bertina, R.M., Prothrombin time ratio is reduced by magnesium contamination in evacuated blood collection tubes. Thromb. Haemost. 85 (2001), 647–650.
62. [62] van den Besselaar, A.M., van Vlodrop, I.J., Berendes, P.B., Cobbaert, C.M., A comparative study of conventional versus new, magnesium-poor Vacutainer(R) sodium citrate blood collection tubes for determination of prothrombin time and INR. Thromb. Res. 134 (2014), 187–191.
63. [63] Drake, S.K., Bowen, R.A., Remaley, A.T., Hortin, G.L., Potential interferences from blood collection tubes in mass spectrometric analyses of serum polypeptides. Clin. Chem. 50 (2004), 2398–2401.
64. [64] Bowen, R.A., Chan, Y., Cohen, J., et al. Effect of blood collection tubes on total triiodothyronine and other laboratory assays. Clin. Chem. 51 (2005), 424–433.
65. [65] Lippi, G., Daves, M., Mattiuzzi, C., Interference of medical contrast media on laboratory testing. Biochem. Med. (Zagreb). 24:1 (Feb 15 2014), 80–88.
66. [66] Bickham, P., Golembiewski, J., Contrast media use in the operating room. J. Perianesth. Nurs. 25 (2010), 94–103.
67. [67] Bellin, M.F., Van Der Molen, A.J., Extracellular gadolinium-based contrast media: an overview. Eur. J. Radiol. 66 (2008), 160–167.
68. [68] Spiritus, T., Zaman, Z., Desmet, W., Iodinated contrast media interfere with gel barrier formation in plasma and serum separator tubes. Clin. Chem. 49 (2003), 1187–1189.
69. [69] Kaleta, E.J., Jaffe, A.S., Baumann, N.A., Block, D.R., A case of floating gel. Clin. Chem. 58 (2012), 1604–1605.
70. [70] Daves, M., Lippi, G., Cosio, G., Raffagnini, A., Peer, E., Dangella, A., et al. An unusual case of a primary blood collection tube with floating separator gel. J. Clin. Lab. Anal. 26 (2012), 246–247.
71. [71] Bossuyt, X., Mewis, A., Blanckaert, N., Interference of radio-opaque agents in clinical capillary zone electrophoresis. Clin. Chem. 45 (1999), 129–131.
72. [72] Lin, C.T., Lee, H.C., Voon, W.C., Yen, H.W., Tang, M.H., Chin, T.T., et al. Positive interference from contrast media in cardiac troponin I immunoassays. Kaohsiung J. Med. Sci. 22 (2006), 107–113.
73. [73] Normann, P.T., Frøysa, A., Svaland, M., Interference of gadodiamide injection (OMNISCAN) on the colorimetric determination of serum calcium. Scand. J. Clin. Lab. Invest. 55 (1995), 421–426.
74. [74] Prince, M.R., Erel, H.E., Lent, R.W., Blumenfeld, J., Kent, K.C., Bush, H.L., Wang, Y., Gadodiamide administration causes spurious hypocalcemia. Radiology 227 (2003), 639–646.
75. [75] Lin, J., Idee, J.M., Port, M., Diai, A., Berthommier, C., Robert, M., et al. Interference of magnetic resonance imaging contrast agents with the serum calcium measurement technique using colorimetric reagents. J. Pharm. Biomed. Anal. 21 (1999), 931–943.
76. [76] Proctor, K.A., Rao, L.V., Roberts, W.L., Gadolinium magnetic resonance contrast agents produce analytic interference in multiple serum assays. Am. J. Clin. Pathol. 121 (2004), 282–292.
77. [77] Darby, D., Broomhead, C., Interference with serum indices measurement, but not chemical analysis, on the Roche Modular by Patent Blue V. Ann. Clin. Biochem. 45 (2008), 289–292.
78. [78] Lippi, G., Avanzini, R., Sandei, F., Aloe, R., Cervellin, G., Blood sample contamination by glucose-containing solutions: effects and identification. Br. J. Biomed. Sci. 70:4 (2013), 180–183.
79. [79] Warner, A., Interference of common household chemicals in immunoassay methods for drugs of abuse. Clin. Chem. 35:4 (Apr 1989), 648–651.
80. [80] Lippi, G., Romero, A., Cervellin, G., Mercadanti, M., Unusual false-positive case of urinary screening for buprenorphine. J. Clin. Lab. Anal. 25:4 (2011), 244–245, 10.1002/jcla.20466.